— Why it moved
Why CELU Stock Spiked and Faded Today — August 27, 2026
Celularity pushed out a flashy news release touting a potential multi-hundred-million-dollar deal, igniting a massive low-float volume surge before the move lost steam.
What moved CELU stock
Celularity is a micro-cap biotech firm focused on cellular therapies out of New Jersey. The stock caught fire after issuing a press release regarding a U.S. manufacturing partnership with MuseCell Innovations, floating potential aggregate purchases over $300 million across five years. Keep in mind the company recently received a Nasdaq non-compliance notice for late quarterly filings.
The mechanics
With a float under 18.9 million shares and a tiny 30-day average volume under 83 thousand, the ticker was ripe for momentum traders to hijack. CELU gapped up 26.08 percent at the session's start and traded over 221 million shares on the day, churning its float more than eleven times.
CELU by the numbers
The alert window
The alert crossed at 10:34 AM at $1.67. Readers had to sit through a brief 4.8 percent dip down to $1.59 before the real push started. It took 30 minutes to top out at $2.55 at 11:04 AM, leaving a clean 52.6 percent sellable window for anyone taking quick profits.
How CELU's move ended
Shares settled at $2.08 by the bell, still up 24.5 percent from the alert. The back-half fade was predictable once the initial buying power dried up. Unfiled financials and historical capital needs mean dilution risk is always lurking in the background.
The tell: Headline revenue projections on micro-caps generate wild morning volume, but unfiled quarterly reports tell you not to hold for the long haul.